These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8043032)

  • 1. Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione.
    Schewe C; Schewe T; Wendel A
    Biochem Pharmacol; 1994 Jul; 48(1):65-74. PubMed ID: 8043032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere.
    Walther M; Holzhütter HG; Kuban RJ; Wiesner R; Rathmann J; Kühn H
    Mol Pharmacol; 1999 Jul; 56(1):196-203. PubMed ID: 10385701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
    Pratta MA; Ackerman NR; Arner EC
    Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzoselenazolinone derivatives designed to be glutathione peroxidase mimetics feature inhibition of cyclooxygenase/5-lipoxygenase pathways and anti-inflammatory activity.
    Galet V; Bernier JL; Hénichart JP; Lesieur D; Abadie C; Rochette L; Lindenbaum A; Chalas J; Renaud de la Faverie JF; Pfeiffer B
    J Med Chem; 1994 Sep; 37(18):2903-11. PubMed ID: 8071938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel biologically active seleno-organic compound--V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase.
    Safayhi H; Tiegs G; Wendel A
    Biochem Pharmacol; 1985 Aug; 34(15):2691-4. PubMed ID: 2990494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular actions of ebselen--an antiinflammatory antioxidant.
    Schewe T
    Gen Pharmacol; 1995 Oct; 26(6):1153-69. PubMed ID: 7590103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ebselen on arachidonate metabolism by ocular and non-ocular tissues.
    Hurst JS; Paterson CA; Bhattacherjee P; Pierce WM
    Biochem Pharmacol; 1989 Oct; 38(19):3357-63. PubMed ID: 2510732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebselen has dehydroascorbate reductase and thioltransferase-like activities.
    Jung CH; Washburn MP; Wells WW
    Biochem Biophys Res Commun; 2002 Mar; 291(3):550-3. PubMed ID: 11855823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of phospholipid hydroperoxide glutathione peroxidase on the activity of lipoxygenases and cyclooxygenases.
    Huang HS; Chen CJ; Suzuki H; Yamamoto S; Chang WC
    Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):65-75. PubMed ID: 10560610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of endothelial nitric oxide synthase by ebselen. Prevention by thiols suggests the inactivation by ebselen of a critical thiol essential for the catalytic activity of nitric oxide synthase.
    Zembowicz A; Hatchett RJ; Radziszewski W; Gryglewski RJ
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1112-8. PubMed ID: 7505326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.
    Patrick RA; Peters PA; Issekutz AC
    Agents Actions; 1993 Nov; 40(3-4):186-90. PubMed ID: 8023742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Mammalian 15-Lipoxygenase by Three Ebselen-like Drugs. A QM/MM and MM/PBSA Comparative Study.
    Cebrián-Prats A; Rovira T; Saura P; González-Lafont À; Lluch JM
    J Phys Chem A; 2017 Dec; 121(51):9752-9763. PubMed ID: 29182862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebselen attenuates oxidative stress in ischemic astrocytes depleted of glutathione. Comparison with glutathione precursors.
    Gabryel B; Małecki A
    Pharmacol Rep; 2006; 58(3):381-92. PubMed ID: 16845212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C2-like beta-barrel domain mediates the Ca2+-dependent resistance of 5-lipoxygenase activity against inhibition by glutathione peroxidase-1.
    Bürkert E; Arnold C; Hammarberg T; Rådmark O; Steinhilber D; Werz O
    J Biol Chem; 2003 Oct; 278(44):42846-53. PubMed ID: 12893830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen.
    Leyck S; Parnham MJ
    Agents Actions; 1990 Jun; 30(3-4):426-31. PubMed ID: 2117337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of seleno-organic compounds on leukotriene B4 biosynthesis].
    Liu DP; Cheng GF; Bai JY; Guo ZR; Zhu XY
    Yao Xue Xue Bao; 1993; 28(6):472-6. PubMed ID: 8249607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisecretory and antiulcer effects of ebselen, a seleno-organic compound, in rats.
    Tabuchi Y; Kurebayashi Y
    Jpn J Pharmacol; 1993 Mar; 61(3):255-7. PubMed ID: 8483303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-oxidation of NADH and NADPH by a mammalian 15-lipoxygenase: inhibition of lipoxygenase activity at near-physiological NADH concentrations.
    O'donnell VB; Kühn H
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):203-8. PubMed ID: 9355754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51).
    Maiorino M; Roveri A; Coassin M; Ursini F
    Biochem Pharmacol; 1988 Jun; 37(11):2267-71. PubMed ID: 3377822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of ebselen on compound 48/80- and anti-IgE-induced histamine release from rat peritoneal mast cells.
    Tchoumkeu-Nzouessa GC; Rebel G
    Biochem Pharmacol; 1998 Dec; 56(11):1525-8. PubMed ID: 9827587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.